Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Juli 2015 09:29 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed

DUBLIN, July 28, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
17. Juli 2015 10:51 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2015 Financial Results

DUBLIN, July 17, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
30. April 2015 08:23 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents

DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
23. April 2015 05:13 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results

DUBLIN, Ireland, April 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
09. April 2015 13:05 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full of Option to Purchase Additional Notes

DUBLIN, Ireland, April 9, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
25. März 2015 12:21 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Filing of 2014 Annual Report

DUBLIN, March 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
03. März 2015 08:47 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Results for Q4 and Fiscal Year 2014

DUBLIN, Ireland, March 3, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
25. Februar 2015 10:44 ET | Quelle: Trinity Biotech plc

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results

DUBLIN, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
23. Februar 2015 10:18 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product

DUBLIN, Ireland, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
16. Dezember 2014 11:26 ET | Quelle: Trinity Biotech plc

Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test

DUBLIN, Ireland, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...

Vorherige Seite